Alternatives to intravenous immunoglobulins in the treatment of immune thrombocytopenic purpura.
David
Michèle
M
Hospital Sainte Justine, Montréal, QC, Canada. davidmi@magellan.umontreal.ca
Chevalier
Isabelle
I
D000367:Age Factors; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D011247:Pregnancy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000628:therapy*; D013156:Splenectomy
D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous